DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00633191 (ClinicalTrials.gov)	November 2003	4/3/2008	Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis	Post Marketing Study of Anti-pseudomonas IgY in Prevention of Recurrence of Pseudomonas Aeruginosa Infections Infections in Cystic Fibrosis (CF) Patients	Cystic Fibrosis;Infection;Pseudomonas Aeruginosa	Drug: Anti-pseudomonas IgY gargle	Immunsystem AB	NULL	Completed	N/A	N/A	Both	14	Phase 1;Phase 2	Sweden

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00633191
(ClinicalTrials.gov)

November 2003

4/3/2008

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis

Post Marketing Study of Anti-pseudomonas IgY in Prevention of Recurrence of Pseudomonas Aeruginosa Infections Infections in Cystic Fibrosis (CF) Patients

Cystic Fibrosis;Infection;Pseudomonas Aeruginosa

Drug: Anti-pseudomonas IgY gargle

Immunsystem AB

NULL

Completed

N/A

Both

Phase 1;Phase 2

Sweden